Filing Flows › Omnicell (OMCL) › Q1 2025
Omnicell (OMCL) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 7, 2025
Omnicell (OMCL) reported revenue of $270M for the first quarter 2025 (Q1 2025), +10% from a year earlier and -12% from the quarter before. Operating margin was -4.3%, net loss $7.0M (2.6% of revenue).
Omnicell, Q1 2025: revenue $270M (+10% year over year), operating margin -4.3%, net loss $7.0M, operating cash flow $25.9M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $270M | -12% | +10% |
| Operating profit | −$11.6M | — | — |
| Net earnings | −$7.0M | — | — |
| Operating cash flow | $25.9M | -54% | -48% |
| Free cash flow | $14.8M | -69% | -64% |
What changed
Revenue was $269.7M in Q1 2025, up 10% year over year and down 12% from the previous quarter. Connected devices, software licenses, and other was the largest line at 45% of revenue. Connected devices, software licenses, and other added $9.0M year over year (up 8%), 38% of the total change.
Gross margin was 41.1%, up 3.5 points from a year earlier. Operating costs exceeded revenue by $11.6M, an operating margin of -4.3%. Operating expenses grew 7% against revenue growth of 10%. The fastest-growing cost line was SG&A (+10%). The quarter ended with a net loss of $7.0M, after a profit of $15.8M the previous quarter. Non-operating items added $2.1M, -22% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was $25.9M (down 48% year over year). Non-cash charges added back $20.0M of depreciation and amortization and $10.8M of share-based compensation. Working capital and other items added $2.2M. Capital expenditures of $11.2M left free cash flow of $14.8M.
Questions
What was Omnicell's revenue in the first quarter 2025?
Omnicell (OMCL) reported revenue of $270M for the first quarter 2025 (Q1 2025), +10% from a year earlier and -12% from the quarter before.
Was Omnicell profitable in the first quarter 2025?
Operating loss was $11.6M (-4.3% of revenue) and net loss $7.0M.
Source: Omnicell 10-Q on SEC EDGAR.